NFKB1 and colitis: In the colonic microenvironment, an enhanced protein expression of PPAR-γ has been reported to abrogate NF-κB pathway and enhance the antioxidant status in the colonic tissue [51,52]; thereby mitigating the colitis symptoms [18].